UAB Esketamine Clinic

The UAB Esketamine Clinic provides Spravato treatment in Birmingham, Alabama. The clinic is part of the UAB Department of Psychiatry and opened in 2020. The clinicians who lead it worked on the original research that led to the approval of Spravato.

Spravato is an FDA approved nasal spray for adults with treatment resistant depression. Patients qualify after trying at least two standard antidepressants, and each visit includes a two hour monitoring period after dosing. A referral from a treating provider is required, so patients should start with their own doctor.

The clinic serves Birmingham and patients from across Alabama and the wider Southeast region.